Acquisitions, Divestitures, Equity-Method Investments, Licensing Arrangement, Collaborative Arrangements and Research and Development Arrangement - Research and Development Arrangement (Details) - Blackstone [Member] - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Apr. 30, 2023	Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Research and development arrangement, maximum funding amount	$ 550
Research and development arrangement, funding to offset costs incurred		$ 175
Clinical Trial Agreement Terms [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Maximum potential consideration	468
Net Sales and Royalty Agreement Terms [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Maximum potential consideration	$ 550